107 related articles for article (PubMed ID: 11522541)
1. Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy.
Allan DS; Kovacs MJ; Clark WF
Haematologica; 2001 Aug; 86(8):844-50. PubMed ID: 11522541
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
3. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura.
Aqui NA; Stein SH; Konkle BA; Abrams CS; Strobl FJ
J Clin Apher; 2003; 18(2):51-4. PubMed ID: 12874815
[TBL] [Abstract][Full Text] [Related]
4. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
Patino W; Sarode R
J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura.
Jilma-Stohlawetz P; Gorczyca ME; Jilma B; Siller-Matula J; Gilbert JC; Knöbl P
Thromb Haemost; 2011 Mar; 105(3):545-52. PubMed ID: 21174003
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
Moake JL
Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504
[TBL] [Abstract][Full Text] [Related]
8. [Thrombocytopenic thrombotic purpura. Retrospective study of 22 consecutive occurrences in 16 patients].
Blanco A; Palacio C; López A; Acebedo G; Castellá D; Juliá A
Med Clin (Barc); 1998 Oct; 111(10):385-8. PubMed ID: 9833242
[TBL] [Abstract][Full Text] [Related]
9. Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura.
Knöbl P; Jilma B; Gilbert JC; Hutabarat RM; Wagner PG; Jilma-Stohlawetz P
Transfusion; 2009 Oct; 49(10):2181-5. PubMed ID: 19538431
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
Lian EC
Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
[TBL] [Abstract][Full Text] [Related]
11. Promising results from cyclophosphamide based immunosuppression therapy of thrombotic thrombocytopenic purpura.
Guzicka-Kazimierczak R; Kazimierczak A; Clark J
Pomeranian J Life Sci; 2015; 61(1):34-40. PubMed ID: 27116852
[TBL] [Abstract][Full Text] [Related]
12. Elective splenectomy in relapsing thrombotic thrombocytopenic purpura.
Real E; Pastor E; Perella M; Grau E
Haematologica; 1998 Oct; 83(10):959-60. PubMed ID: 9830814
[TBL] [Abstract][Full Text] [Related]
13. Oral cyclophosphamide for refractory or relapsing thrombotic thrombocytopenic purpura (TTP).
Hertzberg MS; Koutts J
Aust N Z J Med; 1997 Aug; 27(4):439. PubMed ID: 9448886
[No Abstract] [Full Text] [Related]
14. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
[TBL] [Abstract][Full Text] [Related]
15. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.
Letchumanan P; Ng HJ; Lee LH; Thumboo J
Rheumatology (Oxford); 2009 Apr; 48(4):399-403. PubMed ID: 19202160
[TBL] [Abstract][Full Text] [Related]
16. Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura.
Quintini G; Barbera V; Iannitto E; Spadola V; Fadda R; Greco G; Mazzola G; Mariani G
Transfus Apher Sci; 2003 Oct; 29(2):141-5. PubMed ID: 12941352
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy for the treatment of thrombotic thrombocytopenic purpura.
Kappers-Klunne MC; Wijermans P; Fijnheer R; Croockewit AJ; van der Holt B; de Wolf JT; Löwenberg B; Brand A
Br J Haematol; 2005 Sep; 130(5):768-76. PubMed ID: 16115135
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting remission after high-dose intravenous immunoglobulins in a case of relapsing thrombotic thrombocytopenic purpura.
Castaman G; Rodeghiero F; Ruggeri M; di Bona E; Dini E
Haematologica; 1991; 76(6):511-2. PubMed ID: 1820990
[TBL] [Abstract][Full Text] [Related]
19. Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura.
Marn Pernat A; Buturović-Ponikvar J; Kovac J; Knap B; Premru V; Benedik M; Varl J; Skofic N; Gubensek J; Kersnic B; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):318-21. PubMed ID: 19695067
[TBL] [Abstract][Full Text] [Related]
20. Does cyclophosphamide benefit relapsing thrombotic thrombocytopenic purpura?
Agarwal V; Sharma BL; Aggarwal A; Misra R
J Assoc Physicians India; 2002 Nov; 50():1440-2. PubMed ID: 12583481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
